APO Research
Talk to an analyst

APO RESEARCH · REPORT

Halogenated Hydrocarbon General Anesthetics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Halogenated Hydrocarbon General Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchHalogenated Hydrocarbon General Anesthetics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Halogenated Hydrocarbon General Anesthetics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Halogenated Hydrocarbon General Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Halogenated Hydrocarbon General Anesthetics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Halogenated Hydrocarbon General Anesthetics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Halogenated Hydrocarbon General Anesthetics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Halogenated Hydrocarbon General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Halogenated Hydrocarbon General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Halogenated Hydrocarbon General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Halogenated Hydrocarbon General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Halogenated Hydrocarbon General Anesthetics include AbbVie, Baxter, Halocarbon, Piramal Critical Care, Fujian Haixi United Pharmaceutical Co., Ltd., Hebei Sams Pharmaceutical Co., Ltd., Hebei Yipin Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd. and Shandong New Era Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Halogenated Hydrocarbon General Anesthetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Halogenated Hydrocarbon General Anesthetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Halogenated Hydrocarbon General Anesthetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Halogenated Hydrocarbon General Anesthetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Halogenated Hydrocarbon General Anesthetics Segment by Company

AbbVie

Baxter

Halocarbon

Piramal Critical Care

Fujian Haixi United Pharmaceutical Co., Ltd.

Hebei Sams Pharmaceutical Co., Ltd.

Hebei Yipin Pharmaceutical Co., Ltd.

Lunan Beite Pharmaceutical Co., Ltd.

Shandong New Era Pharmaceutical Co., Ltd.

Shanghai Hengrui Medicine Co., Ltd.

Sichuan Baili Pharmaceutical Co., Ltd.

Halogenated Hydrocarbon General Anesthetics Segment by Type

Sevoflurane

Enflurane

Desflurane

Halogenated Hydrocarbon General Anesthetics Segment by Application

Hospital

Clinic

Other

Halogenated Hydrocarbon General Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Halogenated Hydrocarbon General Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Halogenated Hydrocarbon General Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Halogenated Hydrocarbon General Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Halogenated Hydrocarbon General Anesthetics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Halogenated Hydrocarbon General Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Halogenated Hydrocarbon General Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Halogenated Hydrocarbon General Anesthetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Halogenated Hydrocarbon General Anesthetics Industry Trends Table 2. Halogenated Hydrocarbon General Anesthetics Industry Drivers Table 3. Halogenated Hydrocarbon General Anesthetics Industry Opportunities and Challenges Table 4. Halogenated Hydrocarbon General Anesthetics Industry Restraints Table 5. Global Halogenated Hydrocarbon General Anesthetics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Halogenated Hydrocarbon General Anesthetics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Manufacturers Table 9. Global Halogenated Hydrocarbon General Anesthetics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Halogenated Hydrocarbon General Anesthetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Halogenated Hydrocarbon General Anesthetics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Halogenated Hydrocarbon General Anesthetics Manufacturers, Product Type & Application Table 13. Global Halogenated Hydrocarbon General Anesthetics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Halogenated Hydrocarbon General Anesthetics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sevoflurane Table 17. Major Manufacturers of Enflurane Table 18. Major Manufacturers of Desflurane Table 19. Global Halogenated Hydrocarbon General Anesthetics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021-2026) & (K Units) Table 21. Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2027-2032) & (K Units) Table 22. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2021-2026) Table 23. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2027-2032) Table 24. Global Halogenated Hydrocarbon General Anesthetics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2021-2026) & (K Units) Table 26. Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2027-2032) & (K Units) Table 27. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2021-2026) Table 28. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Halogenated Hydrocarbon General Anesthetics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021-2026) & (K Units) Table 34. Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2027-2032) & (K Units) Table 35. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2021-2026) Table 36. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2027-2032) Table 37. Global Halogenated Hydrocarbon General Anesthetics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2021-2026) & (K Units) Table 39. Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2027-2032) & (K Units) Table 40. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2021-2026) Table 41. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2027-2032) Table 42. Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Halogenated Hydrocarbon General Anesthetics Sales by Region (2021-2026) & (K Units) Table 44. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Region (2021-2026) Table 45. Global Halogenated Hydrocarbon General Anesthetics Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Halogenated Hydrocarbon General Anesthetics Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 49. North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 50. Europe Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 52. Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 59. Global Halogenated Hydrocarbon General Anesthetics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Halogenated Hydrocarbon General Anesthetics Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Halogenated Hydrocarbon General Anesthetics Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Region (2021-2026) Table 63. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Region (2027-2032) Table 64. AbbVie Company Information Table 65. AbbVie Business Overview Table 66. AbbVie Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. AbbVie Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 68. AbbVie Recent Development Table 69. Baxter Company Information Table 70. Baxter Business Overview Table 71. Baxter Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Baxter Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 73. Baxter Recent Development Table 74. Halocarbon Company Information Table 75. Halocarbon Business Overview Table 76. Halocarbon Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Halocarbon Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 78. Halocarbon Recent Development Table 79. Piramal Critical Care Company Information Table 80. Piramal Critical Care Business Overview Table 81. Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 83. Piramal Critical Care Recent Development Table 84. Fujian Haixi United Pharmaceutical Co., Ltd. Company Information Table 85. Fujian Haixi United Pharmaceutical Co., Ltd. Business Overview Table 86. Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 88. Fujian Haixi United Pharmaceutical Co., Ltd. Recent Development Table 89. Hebei Sams Pharmaceutical Co., Ltd. Company Information Table 90. Hebei Sams Pharmaceutical Co., Ltd. Business Overview Table 91. Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 93. Hebei Sams Pharmaceutical Co., Ltd. Recent Development Table 94. Hebei Yipin Pharmaceutical Co., Ltd. Company Information Table 95. Hebei Yipin Pharmaceutical Co., Ltd. Business Overview Table 96. Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 98. Hebei Yipin Pharmaceutical Co., Ltd. Recent Development Table 99. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 100. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 101. Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 103. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 104. Shandong New Era Pharmaceutical Co., Ltd. Company Information Table 105. Shandong New Era Pharmaceutical Co., Ltd. Business Overview Table 106. Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 108. Shandong New Era Pharmaceutical Co., Ltd. Recent Development Table 109. Shanghai Hengrui Medicine Co., Ltd. Company Information Table 110. Shanghai Hengrui Medicine Co., Ltd. Business Overview Table 111. Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 113. Shanghai Hengrui Medicine Co., Ltd. Recent Development Table 114. Sichuan Baili Pharmaceutical Co., Ltd. Company Information Table 115. Sichuan Baili Pharmaceutical Co., Ltd. Business Overview Table 116. Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 118. Sichuan Baili Pharmaceutical Co., Ltd. Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Halogenated Hydrocarbon General Anesthetics Distributors List Table 122. Halogenated Hydrocarbon General Anesthetics Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Halogenated Hydrocarbon General Anesthetics Product Image Figure 2. Global Halogenated Hydrocarbon General Anesthetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Halogenated Hydrocarbon General Anesthetics Market Size (2021-2032) & (US$ Million) Figure 4. Global Halogenated Hydrocarbon General Anesthetics Sales (2021-2032) & (K Units) Figure 5. Global Halogenated Hydrocarbon General Anesthetics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Halogenated Hydrocarbon General Anesthetics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sevoflurane Image Figure 9. Enflurane Image Figure 10. Desflurane Image Figure 11. Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2021-2032) Figure 14. Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2021-2032) Figure 23. Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2021-2032) Figure 26. North America Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 28. U.S. Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 33. Germany Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 40. China Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 48. Brazil Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Halogenated Hydrocarbon General Anesthetics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Halogenated Hydrocarbon General Anesthetics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 59. North America Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 61. Europe Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Halogenated Hydrocarbon General Anesthetics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Halogenated Hydrocarbon General Anesthetics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Sevoflurane
  • Enflurane
  • Desflurane
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AbbVie
  • Baxter
  • Halocarbon
  • Piramal Critical Care
  • Fujian Haixi United Pharmaceutical Co., Ltd.
  • Hebei Sams Pharmaceutical Co., Ltd.
  • Hebei Yipin Pharmaceutical Co., Ltd.
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Shandong New Era Pharmaceutical Co., Ltd.
  • Shanghai Hengrui Medicine Co., Ltd.
  • Sichuan Baili Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Halogenated Hydrocarbon General Anesthetics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Halogenated Hydrocarbon General Anesthetics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Halogenated Hydrocarbon General Anesthetics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Halogenated Hydrocarbon General Anesthetics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Halogenated Hydrocarbon General Anesthetics Market Dynamics
  1. 2.1 Halogenated Hydrocarbon General Anesthetics Industry Trends
  2. 2.2 Halogenated Hydrocarbon General Anesthetics Industry Drivers
  3. 2.3 Halogenated Hydrocarbon General Anesthetics Industry Opportunities and Challenges
  4. 2.4 Halogenated Hydrocarbon General Anesthetics Industry Restraints
3 Halogenated Hydrocarbon General Anesthetics Market by Manufacturers
  1. 3.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Halogenated Hydrocarbon General Anesthetics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Halogenated Hydrocarbon General Anesthetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Halogenated Hydrocarbon General Anesthetics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Halogenated Hydrocarbon General Anesthetics Manufacturers, Product Type & Application
  7. 3.7 Global Halogenated Hydrocarbon General Anesthetics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Halogenated Hydrocarbon General Anesthetics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Halogenated Hydrocarbon General Anesthetics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Halogenated Hydrocarbon General Anesthetics Tier 1, Tier 2, and Tier 3
4 Halogenated Hydrocarbon General Anesthetics Market by Type
  1. 4.1 Halogenated Hydrocarbon General Anesthetics Type Introduction
  2. 4.1.1 Sevoflurane
  3. 4.1.2 Enflurane
  4. 4.1.3 Desflurane
  5. 4.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Type
  6. 4.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021-2032)
  8. 4.2.3 Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type
  10. 4.3.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2021-2032)
  12. 4.3.3 Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2021-2032)
5 Halogenated Hydrocarbon General Anesthetics Market by Application
  1. 5.1 Halogenated Hydrocarbon General Anesthetics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Application
  6. 5.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021-2032)
  8. 5.2.3 Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application
  10. 5.3.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2021-2032)
  12. 5.3.3 Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2021-2032)
6 Global Halogenated Hydrocarbon General Anesthetics Sales by Region
  1. 6.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Region (2021-2032)
  3. 6.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Region (2021-2026)
  4. 6.2.2 Global Halogenated Hydrocarbon General Anesthetics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region
  1. 7.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region
  2. 7.1.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region (2021-2026)
  4. 7.1.3 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region (2027-2032)
  5. 7.1.4 Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032)
  8. 7.2.2 North America Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032)
  11. 7.3.2 Europe Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie
  2. 8.1.1 AbbVie Company Information
  3. 8.1.2 AbbVie Business Overview
  4. 8.1.3 AbbVie Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Halogenated Hydrocarbon General Anesthetics Product Portfolio
  6. 8.1.5 AbbVie Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter Halogenated Hydrocarbon General Anesthetics Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Halocarbon
  14. 8.3.1 Halocarbon Company Information
  15. 8.3.2 Halocarbon Business Overview
  16. 8.3.3 Halocarbon Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Halocarbon Halogenated Hydrocarbon General Anesthetics Product Portfolio
  18. 8.3.5 Halocarbon Recent Developments
  19. 8.4 Piramal Critical Care
  20. 8.4.1 Piramal Critical Care Company Information
  21. 8.4.2 Piramal Critical Care Business Overview
  22. 8.4.3 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Product Portfolio
  24. 8.4.5 Piramal Critical Care Recent Developments
  25. 8.5 Fujian Haixi United Pharmaceutical Co., Ltd.
  26. 8.5.1 Fujian Haixi United Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Fujian Haixi United Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  30. 8.5.5 Fujian Haixi United Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hebei Sams Pharmaceutical Co., Ltd.
  32. 8.6.1 Hebei Sams Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hebei Sams Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  36. 8.6.5 Hebei Sams Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Hebei Yipin Pharmaceutical Co., Ltd.
  38. 8.7.1 Hebei Yipin Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Hebei Yipin Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  42. 8.7.5 Hebei Yipin Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Lunan Beite Pharmaceutical Co., Ltd.
  44. 8.8.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  48. 8.8.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shandong New Era Pharmaceutical Co., Ltd.
  50. 8.9.1 Shandong New Era Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shandong New Era Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  54. 8.9.5 Shandong New Era Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shanghai Hengrui Medicine Co., Ltd.
  56. 8.10.1 Shanghai Hengrui Medicine Co., Ltd. Company Information
  57. 8.10.2 Shanghai Hengrui Medicine Co., Ltd. Business Overview
  58. 8.10.3 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  60. 8.10.5 Shanghai Hengrui Medicine Co., Ltd. Recent Developments
  61. 8.11 Sichuan Baili Pharmaceutical Co., Ltd.
  62. 8.11.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  66. 8.11.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Halogenated Hydrocarbon General Anesthetics Value Chain Analysis
  2. 9.1.1 Halogenated Hydrocarbon General Anesthetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Halogenated Hydrocarbon General Anesthetics Production Mode & Process
  6. 9.2 Halogenated Hydrocarbon General Anesthetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Halogenated Hydrocarbon General Anesthetics Distributors
  9. 9.2.3 Halogenated Hydrocarbon General Anesthetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst